Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Province of Malaga Health Department Hoffmann-La Roche |
---|---|
Information provided by: | Province of Malaga Health Department |
ClinicalTrials.gov Identifier: | NCT00527254 |
The purpose of this study is to evaluate the impact of a a real time teleassistance system in the clinical evolution of type 2 diabetic patients on self monitoring blood glucose in the Public National Primary Care System.
Condition | Intervention |
---|---|
Type 2 Diabetes Telemedicine Self Monitoring Blood Glucose Primary Care |
Device: Telemedicine system |
Study Type: | Interventional |
Study Design: | Supportive Care, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Enrollment: | 328 |
Study Start Date: | October 2003 |
Study Completion Date: | June 2005 |
Arms | Assigned Interventions |
---|---|
Control group: No Intervention | |
Telemedicine group: Active Comparator |
Device: Telemedicine system
Possibility of sending the SMBG values of the patients to a web page via phone mobile sms messages. The HCP had a password access to this web page to check the blood glucose values of the patients and if necessary send to them sms messages with recommendations.
|
The UKPDS study in type 2 diabetes and the DCCT in type 1, showed that intensive blood glucose control and the following HBA1c decrease were associated with a decrease of diabetic complications. Introducing telecontrol elements in the real time follow up of the patients, should help to know continuously patient blood glucose profile and add if necessary immediately therapeutical variations, to maintain HbA1c levels as low as possible. The study compares type 2 diabetes patients performing self monitoring of blood glucose, followed up by their family doctor in their primary care unit with the extra support of a real time teleassistance system with type 2 diabetes patients performing self monitoring of blood glucose, followed up by their family doctor in their primary care unit.
Ages Eligible for Study: | 30 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Spain | |
Province of Malaga Health Department | |
Málaga, Spain, 29001 |
Principal Investigator: | Maria Isabel Rodríguez Idígoras, Doctor | Málaga Health Department (Junta de Andalucia) |
Study ID Numbers: | TeleDiabecom 200501 |
Study First Received: | September 7, 2007 |
Last Updated: | September 7, 2007 |
ClinicalTrials.gov Identifier: | NCT00527254 History of Changes |
Health Authority: | Spain: Comité Ético de Investigación Clínica |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders |